crypto currency units Related searches

In the concept of ice and snow economy, there were many daily limit changes, such as iceberg cold and hot, iceberg cold and hot, Longjian shares and Jingxue energy-saving daily limit, and Dalian Shengya, Changbai Mountain, Yeti shares and Sante ropeway were among the top gainers.Hang Seng Science and Technology Index rose to 1%, while Kewang shares rose, with Billie Billie (09626.HK) rising by over 4%, Baidu (09888.HK) rising by 2.8%, Aauto Quicker (01024.HK), Tencent Holdings (00700.HK) rising by 1.8% and Alibaba (09988.HK) rising by over 1%.The individual pension system has been extended to the whole country. (Xinhua News Agency)

Supreme Law: If the heir abandons the decedent, he shall lose the right of inheritance. On December 12th, the Supreme People's Court released the typical cases of inheritance disputes (the second batch). In case 4, Gao Moujia and Gao Xiaomou are related to each other, and Gao Xiaomou is an only child. In 1992, Gao Xiaomou (at the age of 20) left home after a dispute with his parents, and he never cared about his parents. Mother didn't take care of her when she was ill, and she didn't go to her funeral when she died. When Gao Moujia was seriously ill, he needed transportation, nursing and care for major surgery, but Gao Xiaomou did not appear. After Gao Moujia died, Gao Xiaomou ignored the burial of his ashes, but as the only legal heir, he received some bank deposit certificates under Gao Moujia's name. According to the Supreme Law, the people's court ruled that his behavior constituted abandonment according to law and sentenced him to lose the right of inheritance, which demonstrated the positive guidance of the law to social values, was conducive to carrying forward the traditional virtues of filial piety and respect for the elderly of the Chinese nation, and improved the mechanism for giving play to the role of family education and family style construction in grassroots governance.The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.OPEC continues to lower its global oil demand forecast. According to Xinhua News Agency, the Organization of Petroleum Exporting Countries (OPEC) released its monthly oil market report on the 11th, lowering its global oil demand forecast for 2024 and 2025. This is the fifth time that OPEC has lowered its global oil demand forecast for this year and next since August this year.

BYD's legal department sued the blogger "Xu Lili Xll" and demanded compensation of 5 million yuan. BYD's legal department issued a statement saying that it was concerned that the online user "Xu Lili Xll" had made a lot of false statements against BYD and its sub-brands for a long time, which had caused serious damage to the company's brand reputation. In this regard, the company has fixed the evidence of relevant false statements, and decided to formally file a lawsuit against "Xu Lili Xll", demanding that it delete the infringing statements, eliminate the influence, and compensate RMB 5 million.In the inter-bank market, the yield of the active 10-year treasury bond "24 Treasury Bond with Interest 11" dropped by 1bp to 1.815%. Wind data shows that compared with yield to maturity, a Chinese bond with the same term, it hit a record low.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.